, Tracking Stock Market Picks
Enter Symbol:
Neurogen Corporation (NRGN) [hlAlert]

down 82.17 %

Neurogen Corporation (NRGN) rated Buy by Merriman Curhan Ford

Posted on: Thursday,  Jun 5, 2008  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy Neurogen Corporation (NASDAQ: NRGN) on 06/05/2008, when the stock price was $1.01. Since
then, Neurogen Corporation has lost 82.18% as of 12/23/2010's recent price of $0.18.
If you would have followed this Merriman Curhan Ford's recommendation on NRGN, you would have lost 82.17% of your investment in 931 days.

Neurogen Corp. is a leading drug discovery company. The company engages in both the discovery and development of a broad range of novel small molecule compounds for pharmaceutical uses, and the development and exploitation of cutting-edge drug discovery technologies. The company has diversified the drug discovery and development efforts across a broad number of disease-related targets and across multiple drug candidates for each target.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/5/2008 8:25 AM Buy
as of 12/24/2008
1 Week down  -13.04 %
1 Month up  17.64 %
3 Months up  53.84 %
1 YTD up  42.85 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy